Preferential use of imaging modalities in staging newly diagnosed rectal cancer

A survey of US radiation oncologists

Jehan Belal Yahya, J. Farrell, Daniel Herzig, Catherine R. Degnin, Yiyi Chen, John Holland, Simon Brown, Jerry Jaboin, Charles Thomas, Timur Mitin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background: Accurate staging is crucial for management of patients with newly diagnosed rectal cancer. Endorectal ultrasound (EUS) has been the standard modality in the United States for decades, with magnetic resonance imaging (MRI) now preferred by national guidelines. Positron emission tomography (PET), conversely, is not recommended. The current utilization of imaging modalities by American radiation oncologists in staging newly diagnosed rectal cancer is unknown. Methods: American radiation oncologists completed an anonymous institutional review board-approved online survey probing their imaging preferences for initial staging of rectal cancer patients. Results: We received 220 responses from American radiation oncologists, with 39% in academic centers and with 45% seeing more than 10 rectal cancer patients per year. Most respondents utilize all three imaging modalities for rectal cancer staging-EUS, MRI and positron emission tomography/computed tomography (PET/CT). Fifty-two percent and 38% of respondents are high utilizers of EUS and MRI, respectively, defined as ordering these tests at least 75% of the time. Forty seven percent were high PET utilizers. The latter was associated with practice in a private setting (P=0.015) and being within 10 years from residency training completion (P<0.01). Conclusions: Our analysis reveals a dramatic discordance among national guidelines and the practice patterns among American radiation oncologists. More rely on PET for initial staging of rectal cancer patients than on pelvic MRI. Further research needs to determine the most effective imaging work-up of patients with an initial diagnosis of rectal cancer.

Original languageEnglish (US)
Pages (from-to)435-440
Number of pages6
JournalJournal of Gastrointestinal Oncology
Volume9
Issue number3
DOIs
StatePublished - Jun 1 2018

Fingerprint

Rectal Neoplasms
Magnetic Resonance Imaging
Positron-Emission Tomography
Neoplasm Staging
Research Ethics Committees
Internship and Residency
Radiation Oncologists
Surveys and Questionnaires
Practice Guidelines
Guidelines
Research

Keywords

  • Magnetic resonance imaging (MRI)
  • Neoplasm staging
  • Positive emission topography computed topography (PET/CT)
  • Radiation oncologists
  • Rectal neoplasm

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Preferential use of imaging modalities in staging newly diagnosed rectal cancer : A survey of US radiation oncologists. / Yahya, Jehan Belal; Farrell, J.; Herzig, Daniel; Degnin, Catherine R.; Chen, Yiyi; Holland, John; Brown, Simon; Jaboin, Jerry; Thomas, Charles; Mitin, Timur.

In: Journal of Gastrointestinal Oncology, Vol. 9, No. 3, 01.06.2018, p. 435-440.

Research output: Contribution to journalArticle

@article{600d045572e84e3da63363be572f162f,
title = "Preferential use of imaging modalities in staging newly diagnosed rectal cancer: A survey of US radiation oncologists",
abstract = "Background: Accurate staging is crucial for management of patients with newly diagnosed rectal cancer. Endorectal ultrasound (EUS) has been the standard modality in the United States for decades, with magnetic resonance imaging (MRI) now preferred by national guidelines. Positron emission tomography (PET), conversely, is not recommended. The current utilization of imaging modalities by American radiation oncologists in staging newly diagnosed rectal cancer is unknown. Methods: American radiation oncologists completed an anonymous institutional review board-approved online survey probing their imaging preferences for initial staging of rectal cancer patients. Results: We received 220 responses from American radiation oncologists, with 39{\%} in academic centers and with 45{\%} seeing more than 10 rectal cancer patients per year. Most respondents utilize all three imaging modalities for rectal cancer staging-EUS, MRI and positron emission tomography/computed tomography (PET/CT). Fifty-two percent and 38{\%} of respondents are high utilizers of EUS and MRI, respectively, defined as ordering these tests at least 75{\%} of the time. Forty seven percent were high PET utilizers. The latter was associated with practice in a private setting (P=0.015) and being within 10 years from residency training completion (P<0.01). Conclusions: Our analysis reveals a dramatic discordance among national guidelines and the practice patterns among American radiation oncologists. More rely on PET for initial staging of rectal cancer patients than on pelvic MRI. Further research needs to determine the most effective imaging work-up of patients with an initial diagnosis of rectal cancer.",
keywords = "Magnetic resonance imaging (MRI), Neoplasm staging, Positive emission topography computed topography (PET/CT), Radiation oncologists, Rectal neoplasm",
author = "Yahya, {Jehan Belal} and J. Farrell and Daniel Herzig and Degnin, {Catherine R.} and Yiyi Chen and John Holland and Simon Brown and Jerry Jaboin and Charles Thomas and Timur Mitin",
year = "2018",
month = "6",
day = "1",
doi = "10.21037/jgo.2018.01.19",
language = "English (US)",
volume = "9",
pages = "435--440",
journal = "Journal of Gastrointestinal Oncology",
issn = "2078-6891",
publisher = "Pioneer Bioscience Publishing Company (PBPC)",
number = "3",

}

TY - JOUR

T1 - Preferential use of imaging modalities in staging newly diagnosed rectal cancer

T2 - A survey of US radiation oncologists

AU - Yahya, Jehan Belal

AU - Farrell, J.

AU - Herzig, Daniel

AU - Degnin, Catherine R.

AU - Chen, Yiyi

AU - Holland, John

AU - Brown, Simon

AU - Jaboin, Jerry

AU - Thomas, Charles

AU - Mitin, Timur

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background: Accurate staging is crucial for management of patients with newly diagnosed rectal cancer. Endorectal ultrasound (EUS) has been the standard modality in the United States for decades, with magnetic resonance imaging (MRI) now preferred by national guidelines. Positron emission tomography (PET), conversely, is not recommended. The current utilization of imaging modalities by American radiation oncologists in staging newly diagnosed rectal cancer is unknown. Methods: American radiation oncologists completed an anonymous institutional review board-approved online survey probing their imaging preferences for initial staging of rectal cancer patients. Results: We received 220 responses from American radiation oncologists, with 39% in academic centers and with 45% seeing more than 10 rectal cancer patients per year. Most respondents utilize all three imaging modalities for rectal cancer staging-EUS, MRI and positron emission tomography/computed tomography (PET/CT). Fifty-two percent and 38% of respondents are high utilizers of EUS and MRI, respectively, defined as ordering these tests at least 75% of the time. Forty seven percent were high PET utilizers. The latter was associated with practice in a private setting (P=0.015) and being within 10 years from residency training completion (P<0.01). Conclusions: Our analysis reveals a dramatic discordance among national guidelines and the practice patterns among American radiation oncologists. More rely on PET for initial staging of rectal cancer patients than on pelvic MRI. Further research needs to determine the most effective imaging work-up of patients with an initial diagnosis of rectal cancer.

AB - Background: Accurate staging is crucial for management of patients with newly diagnosed rectal cancer. Endorectal ultrasound (EUS) has been the standard modality in the United States for decades, with magnetic resonance imaging (MRI) now preferred by national guidelines. Positron emission tomography (PET), conversely, is not recommended. The current utilization of imaging modalities by American radiation oncologists in staging newly diagnosed rectal cancer is unknown. Methods: American radiation oncologists completed an anonymous institutional review board-approved online survey probing their imaging preferences for initial staging of rectal cancer patients. Results: We received 220 responses from American radiation oncologists, with 39% in academic centers and with 45% seeing more than 10 rectal cancer patients per year. Most respondents utilize all three imaging modalities for rectal cancer staging-EUS, MRI and positron emission tomography/computed tomography (PET/CT). Fifty-two percent and 38% of respondents are high utilizers of EUS and MRI, respectively, defined as ordering these tests at least 75% of the time. Forty seven percent were high PET utilizers. The latter was associated with practice in a private setting (P=0.015) and being within 10 years from residency training completion (P<0.01). Conclusions: Our analysis reveals a dramatic discordance among national guidelines and the practice patterns among American radiation oncologists. More rely on PET for initial staging of rectal cancer patients than on pelvic MRI. Further research needs to determine the most effective imaging work-up of patients with an initial diagnosis of rectal cancer.

KW - Magnetic resonance imaging (MRI)

KW - Neoplasm staging

KW - Positive emission topography computed topography (PET/CT)

KW - Radiation oncologists

KW - Rectal neoplasm

UR - http://www.scopus.com/inward/record.url?scp=85047530576&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047530576&partnerID=8YFLogxK

U2 - 10.21037/jgo.2018.01.19

DO - 10.21037/jgo.2018.01.19

M3 - Article

VL - 9

SP - 435

EP - 440

JO - Journal of Gastrointestinal Oncology

JF - Journal of Gastrointestinal Oncology

SN - 2078-6891

IS - 3

ER -